IL4 and Parkinson disease: To assess the regulatory impact of TGF-β1-mediated hOM-MSCs on inflammatory factors in the PD cell model, the levels of proinflammatory cytokines (IL-1β and TNF-α) and anti-inflammatory cytokines (IL-4 and IL-10) were assessed in the cell supernatant of each experimental group.